ZNF80
gene geneOn this page
Also known as pT17
Summary
ZNF80 (zinc finger protein 80, HGNC:13155) is a protein-coding gene on chromosome 3q13.31, encoding Zinc finger protein 80 (P51504). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within negative regulation of transcription by RNA polymerase II. Predicted to be located in cytoplasm. Predicted to be active in nucleus.
Source: NCBI Gene 7634 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 43 total
- MANE Select transcript:
NM_007136
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13155 |
| Approved symbol | ZNF80 |
| Name | zinc finger protein 80 |
| Location | 3q13.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | pT17 |
| Ensembl gene | ENSG00000174255 |
| Ensembl biotype | protein_coding |
| OMIM | 194553 |
| Entrez | 7634 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 nonsense_mediated_decay, 1 protein_coding
ENST00000308095, ENST00000482457
RefSeq mRNA: 1 — MANE Select: NM_007136
NM_007136
CCDS: CCDS2979
Canonical transcript exons
ENST00000482457 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001899080 | 114234631 | 114237578 |
Expression profiles
Bgee: expression breadth broad, 70 present calls, max score 70.21.
Top tissues by expression
242 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 70.21 | gold quality |
| lymph node | UBERON:0000029 | 66.05 | gold quality |
| vermiform appendix | UBERON:0001154 | 61.17 | gold quality |
| spleen | UBERON:0002106 | 60.05 | gold quality |
| caecum | UBERON:0001153 | 56.59 | gold quality |
| decidua | UBERON:0002450 | 56.55 | gold quality |
| gall bladder | UBERON:0002110 | 53.07 | gold quality |
| blood | UBERON:0000178 | 52.82 | gold quality |
| hair follicle | UBERON:0002073 | 52.43 | gold quality |
| tonsil | UBERON:0002372 | 52.16 | gold quality |
| bone marrow cell | CL:0002092 | 50.62 | gold quality |
| frontal pole | UBERON:0002795 | 50.41 | gold quality |
| middle frontal gyrus | UBERON:0002702 | 50.30 | gold quality |
| rectum | UBERON:0001052 | 50.23 | gold quality |
| paraflocculus | UBERON:0005351 | 50.18 | gold quality |
| Brodmann (1909) area 10 | UBERON:0013541 | 50.18 | gold quality |
| quadriceps femoris | UBERON:0001377 | 49.70 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 49.61 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 49.59 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.30 | gold quality |
| thymus | UBERON:0002370 | 49.28 | gold quality |
| cerebellar vermis | UBERON:0004720 | 49.25 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 49.20 | gold quality |
| vastus lateralis | UBERON:0001379 | 49.11 | gold quality |
| colonic epithelium | UBERON:0000397 | 49.01 | gold quality |
| olfactory bulb | UBERON:0002264 | 48.92 | gold quality |
| myocardium | UBERON:0002349 | 48.87 | gold quality |
| type B pancreatic cell | CL:0000169 | 48.83 | gold quality |
| oviduct epithelium | UBERON:0004804 | 48.78 | gold quality |
| small intestine | UBERON:0002108 | 48.61 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.64 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
116 targeting ZNF80, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-5193 | 100.00 | 67.26 | 1744 |
| HSA-MIR-518D-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-518E-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-518F-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-519A-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519B-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519C-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-520C-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-522-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-523-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-526A-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-3682-5P | 99.93 | 67.97 | 1163 |
| HSA-MIR-6835-3P | 99.93 | 70.49 | 2904 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300), ZNF70 (ENSG00000187792)
Protein
Protein identifiers
Zinc finger protein 80 — P51504 (reviewed: P51504)
Alternative names: ZNFpT17
All UniProt accessions (1): P51504
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_009067* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096
UniProt features (11 total): zinc finger region 7, sequence variant 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P51504-F1 | 81.08 | 0.47 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 50 (showing top):
SASAKI_ADULT_T_CELL_LEUKEMIA, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, PAX3_TARGET_GENES, MIR548AW, MIR4753_3P, MIR27A_3P_MIR27B_3P, MIR9985, MIR130A_5P, MIR6508_5P, MIR4319, MIR2052, MIR125B_5P, MIR125A_5P, MIR4279
GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
230 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF80 | PRB3 | Q04118 | 671 |
| ZNF80 | GPR15 | P49685 | 600 |
| ZNF80 | FAM187B | Q17R55 | 578 |
| ZNF80 | OR7G3 | Q8NG95 | 561 |
| ZNF80 | SLC22A24 | Q8N4F4 | 489 |
| ZNF80 | CBY2 | Q8NA61 | 466 |
| ZNF80 | ABCA10 | Q8WWZ4 | 427 |
| ZNF80 | CCHCR1 | Q8TD31 | 425 |
| ZNF80 | PI16 | Q6UXB8 | 396 |
| ZNF80 | SERPINI2 | O75830 | 374 |
| ZNF80 | GBP2 | P32456 | 372 |
| ZNF80 | SEMA4D | Q92854 | 371 |
| ZNF80 | KRT83 | P78385 | 367 |
| ZNF80 | KYAT3 | Q6YP21 | 365 |
| ZNF80 | SLC22A10 | Q63ZE4 | 365 |
IntAct
28 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF80 | KRTAP12-3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF80 | CDR2L | psi-mi:“MI:0915”(physical association) | 0.560 |
| GOLGA6L9 | ZNF80 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF80 | VMAC | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF80 | CARD10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF80 | KRT27 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF80 | KRTAP10-9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF80 | CALCOCO2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF80 | HOOK1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF80 | KRTAP12-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF80 | CDR2L | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF80 | GOLGA6L9 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF80 | VMAC | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF80 | CARD10 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF80 | KRT27 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF80 | CALCOCO2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF80 | KRTAP10-9 | psi-mi:“MI:0915”(physical association) | 0.000 |
| HOOK1 | ZNF80 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (11): ZNF80 (Two-hybrid), ZNF80 (Two-hybrid), ZNF80 (Two-hybrid), ZNF80 (Two-hybrid), ZNF80 (Two-hybrid), VMAC (Two-hybrid), GOLGA6L9 (Two-hybrid), KRTAP12-3 (Two-hybrid), KRTAP10-9 (Two-hybrid), ZNF80 (Cross-Linking-MS (XL-MS)), ZNF80 (Two-hybrid)
ESM2 similar proteins: A2RRD8, P10755, P15621, P16372, P16373, P16415, P17030, P17039, P51503, P51504, P51505, P52737, P52741, Q0VGE8, Q13398, Q14584, Q14588, Q147U1, Q3MIS6, Q494X3, Q5RBQ3, Q5REK1, Q61751, Q62981, Q6GQR8, Q6P9A3, Q7TSH9, Q7TSI0, Q8N7K0, Q8N823, Q8N9F8, Q8NA42, Q8NCK3, Q8NDP4, Q8NEP9, Q8TAU3, Q96GE5, Q96HQ0, Q96I27, Q96SK3
Diamond homologs: A2VDP4, A6NDX5, A6NFI3, A6NM28, A6QLU5, A6QPT6, A7MBI1, A8MWA4, B4DU55, E9PYI1, O43296, O60765, O75290, P17023, P17032, P17098, P21506, P51503, P51504, P51505, P51506, P51507, P51508, P51814, P52736, P52738, P52742, Q06730, Q06732, Q08DG8, Q08ER8, Q14592, Q14929, Q16587, Q29RZ4, Q2KI58, Q2M218, Q2M3W8, Q32M78, Q3KQV3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
43 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 34 |
| Likely benign | 3 |
| Benign | 6 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
108 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:114236279:T:TA | donor_gain | 0.7700 |
| 3:114236284:CT:C | donor_gain | 0.7500 |
| 3:114236499:A:AC | donor_gain | 0.7500 |
| 3:114236500:C:CC | donor_gain | 0.7500 |
| 3:114236433:T:A | donor_gain | 0.6900 |
| 3:114236490:C:A | donor_gain | 0.6800 |
| 3:114236489:T:TA | donor_gain | 0.6700 |
| 3:114236283:A:AC | donor_gain | 0.6500 |
| 3:114236284:C:CC | donor_gain | 0.6500 |
| 3:114236500:CTGCA:C | donor_gain | 0.6300 |
| 3:114236500:CTG:C | donor_gain | 0.5200 |
| 3:114236761:CAGGG:C | donor_gain | 0.4700 |
| 3:114236405:T:A | donor_gain | 0.4500 |
| 3:114236278:AT:A | donor_gain | 0.4200 |
| 3:114236317:T:TA | donor_gain | 0.4100 |
| 3:114236501:TG:T | donor_gain | 0.4100 |
| 3:114235715:TTTG:T | donor_gain | 0.4000 |
| 3:114235716:TTGT:T | donor_gain | 0.4000 |
| 3:114236255:A:AC | donor_gain | 0.4000 |
| 3:114235332:CC:C | acceptor_gain | 0.3400 |
| 3:114235333:CC:C | acceptor_gain | 0.3400 |
| 3:114235972:T:TA | donor_gain | 0.3400 |
| 3:114236256:A:C | donor_gain | 0.3400 |
| 3:114236285:T:C | donor_gain | 0.3300 |
| 3:114235329:CGTCC:C | acceptor_loss | 0.3200 |
| 3:114235330:GTCCC:G | acceptor_loss | 0.3200 |
| 3:114235331:TCCC:T | acceptor_loss | 0.3200 |
| 3:114235334:C:A | acceptor_loss | 0.3200 |
| 3:114235335:T:A | acceptor_loss | 0.3200 |
| 3:114235348:C:CT | acceptor_loss | 0.3200 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000267551 (3:114237721 T>C,G), RS1000723915 (3:114237450 T>A), RS1000894236 (3:114238509 C>T), RS1001889907 (3:114239527 A>G), RS1002078353 (3:114238230 A>C,G), RS1002686131 (3:114239140 G>A), RS1002786312 (3:114236038 G>A,C), RS1003184353 (3:114238773 C>T), RS1003627284 (3:114235613 A>C,T), RS1003637135 (3:114235277 G>C), RS1004092455 (3:114237293 T>C,G), RS1004189494 (3:114237341 T>C), RS1005098379 (3:114238243 C>A,T), RS1005143531 (3:114238416 A>T), RS1005400647 (3:114238325 TGCCGTGGAGCAGGGGGCG>T)
Disease associations
OMIM: gene MIM:194553 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003832_1 | Asthma (childhood onset) | 8.000000e-08 |
| GCST003832_17 | Asthma (childhood onset) | 7.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Nickel | increases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Endosulfan | decreases expression | 1 |
| Mercury | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Antirheumatic Agents | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.